Top-News
Biotechnologie USA

Altimmune News

Aktie
WKN:  A2N5Z6 ISIN:  US02155H2004 US-Symbol:  ALT
5,983 €
-0,358 €
-5,65%
17:26:12 Uhr
Handeln Depot/Watchlist
Aktienanzahl *
52,69 Mio.
Marktkapitalisierung *
321,64 Mio. €
Streubesitz
35,90%
Index-Zugehörigkeit
-
IR-Website
zur Website
*Stand: 03.09.2023

Altimmune News

03.07.24 - PR Newswire
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Altimmune
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Altimmune PR Newswire
03.07.24 - PR Newswire
Lost Money on Altimmune, Inc.(ALT)? Join Class Action Suit Seeking Recovery - Contact The Gross Law Firm
Lost Money on Altimmune, Inc.(ALT)? Join Class Action Suit Seeking Recovery - Contact The Gross Law Firm PR Newswire
02.07.24 - PR Newswire
ALT Investors Have Opportunity to Lead Altimmune, Inc. Securities Fraud Lawsuit
ALT Investors Have Opportunity to Lead Altimmune, Inc. Securities Fraud Lawsuit PR Newswire
02.07.24 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Altimmune, Inc. of Class Action Lawsuit and Upcoming Deadlines - ALT
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Altimmune, Inc. of Class Action Lawsuit and Upcoming Deadlines - ALT ...
01.07.24 - PR Newswire
Altimmune, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before July 5, 2024 to Discuss Your Rights - ALT
Altimmune, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before July 5, 2024 to Discuss Your Rights - ALT PR Newswire
29.06.24 - PR Newswire
ALT Deadline: ALT Investors Have Opportunity to Lead Altimmune, Inc. Securities Fraud Lawsuit
ALT Deadline: ALT Investors Have Opportunity to Lead Altimmune, Inc. Securities Fraud Lawsuit PR Newswire
28.06.24 - PR Newswire
Lost Money on Altimmune, Inc.(ALT)? Join Class Action Suit Seeking Recovery - Contact The Gross Law Firm
Lost Money on Altimmune, Inc.(ALT)? Join Class Action Suit Seeking Recovery - Contact The Gross Law Firm PR Newswire
27.06.24 - PR Newswire
ALT Investors Have Opportunity to Lead Altimmune, Inc. Securities Fraud Lawsuit
ALT Investors Have Opportunity to Lead Altimmune, Inc. Securities Fraud Lawsuit PR Newswire
26.06.24 - PR Newswire
DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Altimmune
DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Altimmune PR Newswire
26.06.24 - PR Newswire
Contact Levi & Korsinsky by July 5, 2024 Deadline to Join Class Action Against Altimmune, Inc.(ALT)
Contact Levi & Korsinsky by July 5, 2024 Deadline to Join Class Action Against Altimmune, Inc.(ALT) PR Newswire
25.06.24 - PR Newswire
Shareholders that lost money on Altimmune, Inc.(ALT) should contact The Gross Law Firm about pending Class Action - ALT
Shareholders that lost money on Altimmune, Inc.(ALT) should contact The Gross Law Firm about pending Class Action - ALT PR Newswire
24.06.24 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Altimmune, Inc. of Class Action Lawsuit and Upcoming Deadlines - ALT
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Altimmune, Inc. of Class Action Lawsuit and Upcoming Deadlines - ALT ...
21.06.24 - PR Newswire
ALT Investors Have Opportunity to Lead Altimmune, Inc. Securities Fraud Lawsuit
ALT Investors Have Opportunity to Lead Altimmune, Inc. Securities Fraud Lawsuit PR Newswire
21.06.24 - PR Newswire
Altimmune, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before July 5, 2024 to Discuss Your Rights - ALT
Altimmune, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before July 5, 2024 to Discuss Your Rights - ALT PR Newswire
20.06.24 - PR Newswire
ALT Investors Have Opportunity to Lead Altimmune, Inc. Securities Fraud Lawsuit
ALT Investors Have Opportunity to Lead Altimmune, Inc. Securities Fraud Lawsuit PR Newswire
20.06.24 - PR Newswire
Altimmune, Inc. Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before July 5, 2024 to Discuss Your Rights - ALT
Altimmune, Inc. Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before July 5, 2024 to Discuss Your Rights - ALT PR Newswire
18.06.24 - PR Newswire
ALT Investors Have Opportunity to Lead Altimmune, Inc. Securities Fraud Lawsuit
ALT Investors Have Opportunity to Lead Altimmune, Inc. Securities Fraud Lawsuit PR Newswire
18.06.24 - PR Newswire
ALT LAWSUIT ALERT: Levi & Korsinsky Notifies Altimmune, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
ALT LAWSUIT ALERT: Levi & Korsinsky Notifies Altimmune, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline PR Newswire
17.06.24 - PR Newswire
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of July 5, 2024 in Altimmune, Inc. Lawsuit - ALT
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of July 5, 2024 in Altimmune, Inc. Lawsuit - ALT PR Newswire
15.06.24 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Altimmune, Inc. of Class Action Lawsuit and Upcoming Deadlines - ALT
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Altimmune, Inc. of Class Action Lawsuit and Upcoming Deadlines - ALT ...

Newssuche

Videos

03.07.24 +2,29%
Technical Trading: Bund Future Long Chance
Bund Future Long Typ: Turbo Open End WKN: VM3CG4 Hebel: 7,32 Laufzeit: OpenEnd Einstieg: Market ... Mehr »